Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action
Zukela Ruzi, Khurshed Bozorov, Lifei Nie, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113948-113948
Open Access | Times Cited: 20

Showing 20 citing articles:

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
Yingqian Zhang, Chenyuan Wu, Nana Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12724-12724
Open Access | Times Cited: 50
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 28
Sulfoxidation of pyrimidine thioate derivatives and study their biological activities
Atif A. El‐Gharably, Amal A. Nassar, N. M. El-Ganzory, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
A review of recent advances in anticancer activity and SAR of pyrazole derivatives
Heba A. Hofny, Mamdouh F. A. Mohamed, Heba A. Hassan, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Saponins: Natural Surfactants and their Alternative Sustainability in the Formulation of Bio-Based Detergents to Mitigate Environmental Pollution
Myriam Rojas, Yanha Ortiz, David Arturo, et al.
Waste and Biomass Valorization (2024) Vol. 15, Iss. 10, pp. 5965-5982
Closed Access | Times Cited: 2
Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties
Zukela Ruzi, Khurshed Bozorov, Lifei Nie, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106506-106506
Closed Access | Times Cited: 6
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Furo[2,3‐d]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study
Buer Song, Lifei Nie, Khurshed Bozorov, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 3
Closed Access | Times Cited: 5
Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022)
Atukuri Dorababu
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 416-432
Closed Access | Times Cited: 4
Synthesis of tricyclic pyrazolopyrimidine arylidene ester derivatives and their cytotoxic and molecular docking evaluations
Tong Lu, Lifei Nie, Danling Tang, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 4, pp. 651-668
Closed Access | Times Cited: 1
Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives
Zheng Yang, Yu Wang, Mourboul Ablise, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107498-107498
Closed Access | Times Cited: 1
Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents
Prashant Chaudhari, Aditya Ramchandra Nemade, Atul A. Shirkhedkar
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33384-33417
Open Access | Times Cited: 1
Imidazo- and pyrazolopyrimidine scaffolds as anticancer agents
Ghada Rady, Moshira El Deeb, Marwa T. Sarg, et al.
Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences (2023) Vol. 4, Iss. 1, pp. 107-143
Open Access | Times Cited: 3
Parallel synthesis of condensed pyrimidine-thiones and their antitumor activities
Buer Song, Lifei Nie, Khurshed Bozorov, et al.
Research on Chemical Intermediates (2022) Vol. 49, Iss. 4, pp. 1327-1348
Closed Access | Times Cited: 5
Recent Advances on Pyrazole-Pyrimidine/Fused Pyrimidine Hybrids with Anticancer Potential (A Review)
S. WANG, S. S. Qian, Sheng Wang, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 8, pp. 2090-2112
Closed Access | Times Cited: 2
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential
Zhi Xu, Li Wang, Hongyan Hu
Archiv der Pharmazie (2024)
Closed Access
Multifunctional Pyrazolo[3,4-d]Pyrimidine Analogs (HCQ-PPs): Design, Synthesis and Anti-SARS-CoV-2 Evaluation
Khaled Alseud, Mahrous A. Abou-Salim
Polycyclic aromatic compounds (2024), pp. 1-22
Closed Access
Synthesis and Cytotoxic Activity of a New Derivative of Rupestonic Acid
Paruke Aibibula, Haji Akber Aisa, Khurshed Bozorov, et al.
Chemistry of Natural Compounds (2023) Vol. 59, Iss. 6, pp. 1102-1108
Closed Access | Times Cited: 1
XINAZOLIN ALKALOIDLARINING TIOFENLI ANALOGLARI: 2-N(ALKIL, ARIL)-TIENO[2,3-D]PIRIMIDINONLARNING SINTEZI VA MODIFIKASIYASI
Ibrohimjon Rahmonovich Asqarov, Haji Akber Aisa, Khurshed Bozorov, et al.
Deleted Journal (2022) Vol. 1, Iss. 5, pp. 55-76
Open Access | Times Cited: 1
SARATONGA QARSHI 1,2,3-TRIAZOL-SAQLAGAN BIRIKMALAR
Anvarjon Yusuf o’g’li Buronov, Zarifa Isakulovna Murtazayeva, Davlat Bobomurodovich Tuxtayev, et al.
Deleted Journal (2023) Vol. 2, Iss. 2, pp. 221-240
Open Access
Page 1

Scroll to top